Daily Stock List
GeoVax Labs, Inc. (GOVX)
Wall Street Resources, SmallCapStockPlays, ProActive Capital, IRGnews Alert, FeedBlitz, SmallCapVoice, M2 Communications, Standout Stocks, Stockpalooza, Stock Stars, PennyTrader.com, DrStockPick, PennyOmega, CoolPennyStocks, HotOTC, and Penny Performers reported on GeoVax Labs, Inc. (GOVX), and we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Smyrna, Georgia based GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines using its novel DNA/MVA vaccine delivery platform. The Company's lead development programs are focused on the Ebola virus and the Human Immunodeficiency Virus (HIV). On the whole, GeoVax's vaccines, in various doses and combinations, have been tested in almost 500 people. GeoVax lists on the OTC Markets Group’s OTCQB.
Its vaccine technology was developed in association with researchers at Emory University, the NIH, and the CDC. The technology developed by the collaboration is exclusively licensed to GeoVax Labs from Emory University. Moreover, GeoVax has non-exclusive licenses to certain patents owned by the NIH.
The design of GeoVax’s unique, two component vaccine, a recombinant DNA and a recombinant modified vaccinia Ankara (MVA), is to stimulate anti-HIV antibody and anti-HIV T cell immune responses. The Company’s DNA and MVA vaccines are used in a prime/boost protocol in which priming is done with the DNA and boosting with the MVA.
Both the DNA and MVA express the three major proteins of the HIV virus: Gag, Pol, and Env, and produce non-infectious virus-like-particles. The Company’s vaccines are unique in expressing virus-like particles, which display the native form of the trimeric membrane-bound HIV-1 envelope glycoprotein.
Clinical trials for GeoVax Labs’ preventive HIV vaccines have been conducted by the U.S. National Institutes of Health-supported HIV Vaccine Trials Network (HVTN) with funding from the National Institute of Allergy and Infectious Disease (NIAID).
GeoVax earlier completed the first Phase 1 trial (GV-TH-01) investigating the therapeutic potential of its DNA/MVA vaccine regimen (GOVX-B11) in HIV-infected patients. It announced preliminary results of the trial in early 2014.
Pertaining to GeoVax’s Preventive HIV Vaccine Program, all of the human clinical trials of its preventive HIV vaccines have been conducted by the HIV Vaccine Trials Network (HVTN) with funding from the NIH. The most recent of these clinical trials (HVTN 094), a Phase 1 study of GOVX-B21, was completed in late 2013. Based on analysis of all available data generated so far, GeoVax is advancing GOVX-B11 to the next stage of human clinical testing. The Company is in planning discussions with the HVTN and NIH for a Phase 2b efficacy trial.
Today, GeoVax Labs provided an update on its Ebola virus vaccine development program. This past October, the Company announced its initiation of a new program for the development of vaccines to prevent Ebola virus infection. GeoVax is developing two Ebola vaccines, GOVX-E301 and GOVX-E302. Its proprietary Ebola vaccine technology was developed internally.
GeoVax Labs, Inc. (GOVX), closed Monday's trading session at $0.16, up 6.67%, on 50,473 volume with 15 trades. The average volume for the last 60 days is 123,893 and the stock's 52-week low/high is $0.1306/$0.60.
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Wall Street Resources reported recently on Corbus Pharmaceuticals Holdings, Inc. (CRBP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Corbus Pharmaceuticals Holdings, Inc. is an emerging drug development company based in Norwood, Massachusetts. The Company focuses on the development and commercialization of its lead product candidate, Resunab™. This product is for the treatment of rare, life-threatening inflammatory and fibrotic diseases. In essence, Corbus Pharmaceuticals is a clinical stage pharmaceutical company concentrating on the development and commercialization of novel therapeutics to treat rare life-threatening inflammatory-fibrotic diseases with clear unmet medical needs.
This past October, Corbus Pharmaceuticals Holdings announced that shares of the Company's common stock initiated trading on the Over-the-Counter Markets (OTCQB) under the ticker symbol CRBP. Yuval Cohen, Ph.D., CEO of Corbus Pharmaceuticals, stated, "We are very pleased to have reached this major corporate milestone so quickly and list as a public company."
The Company’s Resunab™ is a first in class, oral anti-inflammatory drug that acts to resolve inflammation. It is a novel synthetic oral drug with unique anti-inflammatory and anti-fibrotic activity. Pre-clinical and Phase 1 studies have shown Resunab™ to have a favorable safety profile together with promising potency in pre-clinical models of inflammation and fibrosis. Resunab™ binds to the CB2 receptor of immune cells and triggers a process called "inflammatory resolution." This in effect turns chronic inflammation off.
The expectation is that Resunab™ will enter Phase 2 clinical trials pending Food and Drug Administration (FDA) approval of Corbus’ Investigational New Drug (IND) filed in Q4 2014. Further to a recent $10.3 million in financing, the Company has also secured $1.3 million in grant based funding for the development of Resunab™.
Resunab™ addresses the multi-billion dollar rare disease markets. Initial indications for it are Cystic Fibrosis and Scleroderma. Resunab™ is entering two Phase 2 trials this year. It has a demonstrated safety profile in Phase 1 (121 subjects) and promising pre-clinical potency in multiple models.
Last week, Corbus Pharmaceuticals Holdings announced that its CEO, Yuval Cohen, Ph.D., will be presenting at two upcoming investor conferences in January 2015. One is the Biotech Showcase 2015, Wednesday, January 14, 2015, 2:00 p.m. Pacific Time/5:00 p.m. Eastern Time (Parc 55 Wyndham Union Square, San Francisco, California). The other is the Noble Financial Capital Markets' 11th Annual Investor Conference, Tuesday, January 20, 2015, 9:00 a.m. Eastern Time (Club Med, Sandpiper Bay, Florida).
Corbus Pharmaceuticals Holdings, Inc. (CRBP), closed Monday's trading session at $2.75, down 8.64%, on 4,700 volume with 6 trades. The average volume for the last 60 days is 7,784 and the stock's 52-week low/high is $2.58/$4.95.
GAWK, Inc. (GAWK)
Penny Pick Insider, Penny Stocks VIP, Daily Stock Motion, Wallstreet Profiler, PennyDoctor, StockRunway, Penny Pick Insider, and StockMister reported earlier on GAWK, Inc. (GAWK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Los Angeles, California headquartered GAWK, Inc. is an international innovator of self-service global digital distribution. It can stream all forms of digital media. This includes, but is not limited to, movies, documentaries, TV shows, music videos, vlogs, digital books, digital shorts, social networking videos, and video game entertainment. GAWK’s shares trade on the OTC Markets’ OTCQB.
The Company provides an inventive platform and interactive social network for artists to capitalize on their creativity by way of the GAWK self-service model of Post, Price and Promote. The Pay per GAWK model offers a simplistic and economical transaction experience with each purchase. There are no subscription fees and no hidden costs.
GAWK purchased WebRunners, Inc., on November 5, 2014, for over $1 million in a combination of cash and stock as part of its plan to create revenue by acquiring data centers to offload the massive amounts of data produced by the major wireless cell phone companies. WebRunners is an Irvine, California-headquartered data center.
WebRunners, a wholly-owned subsidiary of GAWK, is a Tier III site, built by AT&T. WebRunners is an Internet service provider specializing in virtualization, high-availability hosting, and storage and professional Information Technology (IT) services. It is a former Verio/NTT facility with carrier-grade equipment in place. Moreover, GAWK has identified thirteen more firms as potential acquisition targets.
In early December 2014, GAWK announced a signature client win with the signing of an agreement with WAHLCO, Inc. (Wahlco), an International Company. Wahlco’s speciality is in the design and manufacture of Industrial Air Pollution Control Equipment. Wahlco offers full-spectrum field support. This includes installation supervision, commissioning, maintenance, equipment upgrades, rentals, and replacement parts.
Furthermore, in December, GAWK announced another signature client win with the signing of an agreement with Top Shelf Fixtures, Inc., Top-Shelf engineers, designs, and manufactures retail store fixtures for mass merchandisers, grocery chains, franchise companies, as well as users of POP displays. Top Shelf Fixtures is a leading Manufacturer of Custom Store Fixture Displays and a Metal Fabricator for the Appliance Industries and other Original Equipment Manufacturer (OEM) Markets.
GAWK’S multidimensional strategic approach produces continuing and long-term revenue opportunities. It does so via independent content publishing, creative entertainment viewing, product integration, sponsorship, and advertising.
GAWK, Inc. (GAWK), closed Monday's trading session at $0.0199, up 24.38%, on 140,857 volume with 16 trades. The average volume for the last 60 days is 157,303 and the stock's 52-week low/high is $0.011/$8.65.
AudioEye, Inc. (AEYE)
Wall Street Resources, PennyStocks24, BUYINS.NET, FreeRealTime, and Monster Stocks reported on AudioEye, Inc. (AEYE), and we highlight the Company today, here at the QualityStocks Daily Newsletter.
AudioEye, Inc.’s focus is on working to improve the mobility, usability, as well as accessibility of all Internet-based content. This is through the development, sale, licensing and use of its proprietary accessibility technologies. OTCQB-listed AudioEye has developed patented Internet content publication and distribution software. It enables the conversion of any media into an audio-accessible format. It also allows for real-time distribution to end-users on any Internet-connected device. Incorporated in 2005, AudioEye has its corporate headquarters in Tucson, Arizona.
The Company is the creator of the world’s first and only cloud-based cross-platform/cross-browser screen reader solution for web browsing. AudioEye’s emphasis is to provide solutions that create better and more complete access to the Internet, print, broadcast, and other media. This is regardless of one’s network connection, device, location, or specific abilities. Its solutions additionally include all-inclusive E-Learning and E-Commerce systems, along with a variety of Internet publishing products and services.
The AudioEye Web A11Y Management Platform provides publishers full control over the accessibility of their web assets and web environments. This allows the publisher to recognize, remediate, as well as report its real-time accessibility status. AudioEye helps empower website publishers to comply with web accessibility best practices and standards. The Company launched its Web A11y Platform, which provides a complete, multi-layered solution for organizations looking to comply with Section 508 best practices.
The Company’s technology utilizes AudioEye’s patented architecture to deliver a fully accessible audio equivalent of a visual website or mobile website in a compliant format that can be navigated, utilized, interacted with, and transacted from without the use of a monitor or mouse, by individuals with visual impairments.
For individuals with hearing impairments, its technology provides captioning for websites. Furthermore, the challenges of reaching those with other impairments are also addressed by the technology platform. The AudioEye Platform is a fully scalable cloud-based solution.
Today, AudioEye announced that it expects to report results for the fourth quarter and year ended December 31, 2014 on or before March 31, 2015. It expects to report at least $3.25 million in revenue for the three months ended December 31, 2014. This compares with roughly $0.75 million in the previous-year quarter. This represents a year-over-year increase of over 332 percent. Revenue for the twelve months ended 2014 and 2013 approximated $12 million and $1.56 million, respectively. This represents a year-over-year increase of over 665 percent. Based on information presently available, AudioEye expects to be profitable for the year ended December 31, 2014.
AudioEye, Inc. (AEYE), closed Monday's trading session at $0.49, up 22.81%, on 647,892 volume with 125 trades. The average volume for the last 60 days is 143,033 and the stock's 52-week low/high is $0.246/$1.18.
Tauriga Sciences, Inc. (TAUG)
Greenbackers, TheMicrocapNews, Wallstreetlivechat, PennyStocks Forever, Stock Tips Network, Stock Analyzer, PennyStocks24, Xtremepicks, Penny Stock Rumble, and OurHotStockTips reported earlier on Tauriga Sciences, Inc. (TAUG), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.
Tauriga Sciences, Inc. is a diversified life sciences company focused on generating profitable revenues in the natural wellness sector and in developing a proprietary synthetic biology platform technology. The Company’s business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, as well as entire businesses. It also has its acquisition in the cannabis space. The OTCQB listed Company previously went by the name Immunovative, Inc. It changed its name to Tauriga Sciences, Inc. in March 2013.
On January 28, 2014, the Company announced that it completed the acquisition of Cincinnati, Ohio-based synthetic biology pioneer Pilus Energy, LLC. Pilus Energy is now a wholly-owned subsidiary of Tauriga Sciences. Pilus maintains its headquarters location in Ohio.
Tauriga Sciences has been working to establish a global presence by way of partnerships and global exclusive licenses. This is because its proprietary BactoBot technology can potentially address many global water related issues.
Subsidiary Pilus Energy is a developer of alternative cleantech energy platforms employing proprietary microbial solutions that creates electricity while consuming polluting molecules from wastewater. In the process, the technology generates electricity and produces economically important gases and chemicals. Pilus Energy licenses a low-cost, scalable electrogenic bioreactor platform and wastewater-to-value BactoBots. Pilus Energy will also gain added revenues from carbon and renewable energy credits (REC).
Tauriga Sciences announced in May 2014 that it entered into its first retail distribution agreement for its new line of natural medicine products. The Company’s natural medicine product line includes non-cannabis containing candies, gums, and supplements with proprietary formulations designed to address unwanted cannabis-related effects. Tauriga has launched Cannabis Complements, which is its line of natural dietary supplements that address cannabis-related effects but that do not contain cannabis oil.
Tauriga announced in July 2014 that it completed its acquisition of California-based medicinal cannabis firm Honeywood LLC. Honeywood is the formulator for Doc Green's topical cannabis cream and other products. This past September, Tauriga announced the restructuring of its acquisition of Honeywood into a License and Supply Agreement that provides Tauriga Sciences access to the Doc Green's topical cannabis cream and future products.
Last month, Tauriga Sciences announced that it launched its first proprietary topical medicinal cannabis cream branded as TopiCanna. TopiCanna contains cannabidiol (CBD) oil from non-GMO industrial hemp that is grown without pesticides, herbicides, or chemical fertilizers.
Last week, Tauriga Sciences announced that it launched its www.taurigastore.com eCommerce website. This launch allows consumers to shop online with Tauriga for its non-cannabis containing line of natural wellness dietary supplements.
Tauriga Sciences, Inc. (TAUG), closed Monday's trading session at $0.0161, down 7.47%, on 3,500,163 volume with 50 trades. The average volume for the last 60 days is 3,024,922 and the stock's 52-week low/high is $0.0051/$0.1075.
Electronic Cigarettes International Group, Ltd. (ECIG)
Top Stock Picks, Pennybuster, StockRockandRoll, TheMicrocapNews, Street Insider, and The Street reported earlier on Electronic Cigarettes International Group, Ltd. (ECIG), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.
Founded in 2010, Electronic Cigarettes International Group, Ltd. (ECIG) is a global marketer and distributor of electronic cigarette and vapor products. The Company’s dedication is to offering an alternative to traditional cigarettes. Its brands include VAPESTICK®, FIN®, Victory®, VIP® and others. The OTCQB-listed Company formerly went by the name Victory Electronic Cigarettes Corp. It changed its corporate name to Electronic Cigarettes International Group, Ltd. in July 2014.
ECIG owns many subsidiary companies and has operations in North America, Western Europe, as well as Asia Pacific. It started online sales in 2012. ECIG became a publicly traded company on June 25, 2013. The Company offers consumers a full product portfolio, which integrates product quality and the latest technology.
ECIG manages the development, supply chain, marketing, sales, and distribution of electronic cigarettes (E-Cigarettes) and their components via the internet and retail outlets internationally. ECIG brands offer a line of disposable cig-a-like items, or non-rechargeable or disposable electronic cigarettes. These products are available in an assortment of flavors and nicotine strengths.
In addition, the Company offers rechargeable kits, introductory vaping kits, and advanced vaping kits. It also offers speciality products: electronic cigars, v-shisha, and E-hookahs among others. Additionally, the Company offers accessories: carrying cases, lanyards, and American and European style chargers.
Last month, ECIG announced that VIP®, one of the United Kingdom’s (UK’s) leading e-cigarette brands and a wholly-owned subsidiary of ECIG, opened its first dedicated ‘Blending Boutique’ in East London. This is the first of its type in the UK. The boutique debuted in Westfield Stratford City shopping center. It adds to the number of VIP® outlets in the UK and Europe to now greater than 120.
Last week, ECIG announced that it began a major new national advertising campaign behind the FIN® Advanced Vaping System in the U.S. The campaign supports the expansion of the ECIG’s Advanced Vaping System “AVS”. This is one of the Company’s most successful product launches in its history that has expanded to over 30,000 accounts in the U.S. and Europe.
Electronic Cigarettes International Group, Ltd. (ECIG), closed Monday's trading session at $0.0476, up 0.63%, on 11,624,751 volume with 574 trades. The average volume for the last 60 days is 8,674,040 and the stock's 52-week low/high is $0.0326/$19.99.
Endeavor IP, Inc. (ENIP)
Greenbackers, Pumps and Dumps, AnotherWinningTrade, Investment House, Market FN, Stock Research Newsletter, The Best Newsletters, YOLOTraderAlerts, Todd Horwitz, The Stock Enthusiast, The Trading Report, HoleinOneStocks.net, Wyatt Investment Research, Ascending Stocks, Value Penny Stocks, Investopedia, BillionaireStocks, StreetAuthority Financial, HotStockProfits, and Microcap MarketPlace reported earlier on Endeavor IP, Inc. (ENIP), and we are highlighting the Company as well, here at the QualityStocks Daily Newsletter.
New York, New York headquartered Endeavor IP, Inc. is an intellectual property (IP) services and patent licensing company. It engages in the acquisition and licensing of IP. The Company combines investment strategy, technology, as well as best practices in the monetization of patents. Its focus is on investors, inventors, and its patent partners. Endeavor IP only defends patents with the potential to yield highly successful results. The Company formerly went by the name Finishing Touches Home Goods, Inc. It changed its name to Endeavor IP, Inc. in May 2013. The Company’s shares trade on the OTC Bulletin Board.
Endeavor IP offers a portfolio approach to IP investing that lessens risk and maximizes returns. It is technology agnostic and applies modern investment management techniques to the patent sector. Endeavor IP believes in protecting and aggressively enforcing the IP rights of inventors. Its leadership team includes individuals from science and law to financial analysis and technology.
This past October, Endeavor IP announced that Endeavor MeshTech, Inc. received an Issue Notice from the United States Patent and Trademark Office (USPTO) for U.S. Patent No. 8,855,019 that relates to a wireless communication enabled meter and network. Endeavor MeshTech is a wholly-owned subsidiary of Endeavor IP.
Last week, Endeavor IP announced that Endeavor MeshTech entered into a license and settlement agreement with EnergyHub, Inc. The EnergyHub settlement represents the fifth settlement Endeavor IP reached regarding its MeshTech patent portfolio in 2014. In October 2014, MeshTech filed six patent infringement lawsuits in different U.S. District Courts asserting claims of patent infringement related to U.S. Patent Nos. 7,379,981 (the 981 Patent); 8,700,749 (the 749 Patent); and 8,855,019 (the 019 Patent).
Mr. Franciscus Diaba, President of Endeavor IP, said, "With the announcement of the license and settlement agreement with EnergyHub, we have successfully settled two of six lawsuits, related to the MeshTech patent portfolio, we filed approximately eight weeks ago. We look forward to continuing our monetization program."
Endeavor IP, Inc. (ENIP), closed Monday's trading session at $0.0131, up 1.16%, on 558,000 volume with 4 trades. The average volume for the last 60 days is 152,017 and the stock's 52-week low/high is $0.012/$0.775.
Pure Hospitality Solutions, Inc. (PNOW)
The QualityStocks Daily Newsletter would like to spotlight Pure Hospitality Solutions, Inc. (PNOW). Today, Pure Hospitality Solutions, Inc. closed trading at $0.0597, up 19.40%, on 224,599 volume with 32 trades. The stock’s average daily volume over the past 60 days is 12,247, and its 52-week low/high is $0.0031/$0.9412.
Pure Hospitality Solutions, Inc. announced today, the Company's newly re-tooled, FROL (Friendly Reservation Online) online hotel booking engine, will be re-launched as Oveedia; positioned as the GDS/IDS/OTA and mobile hub for the Central American-Caribbean region's Latin countries. Management indicated that it's widely believed that PURE is in the right place at the right time; especially with the recent U.S. policy change toward Cuba. While there has always been tourism to parts of Central America and the Caribbean, the majority has been to better known areas of the Dominican Republic, Belize and Costa Rica.
Pure Hospitality Solutions, Inc. (PNOW) is a provider of proprietary technology, marketing solutions, infrastructure and branding services to hotel operators.
The company's innovative platform functions as a powerful vehicle to help hotel operators achieve greater success in three specific areas: (i) expanded international exposure and recognition, (ii) powerful core structure, and (iii) high occupancy rates that drive increases in bottom-line profits. Pure continuously refines its suite of proprietary solutions to deliver measurable and proven results to hotel properties. This success has been reflected in those properties operating under the Hotel PURE brand as well as with independent boutique hotel properties utilizing the company's Friendly Reservation Online (FROL) booking engine technology and internet marketing services.
Operating a successful bi-lateral business model, Pure has four objectives:
1. To franchise the Hotel PURE brand to selected hotel properties worldwide similar to the business model currently employed by Big Brand operators such as Holiday Inn, Marriott, Sheraton and others;
2. Provide highly efficient and economical back-end booking engine technology services to independently branded boutique hotels that require a robust online presence;
3. Launch a stand-alone online hotel booking search engine primarily focused on Central America; and,
4. Expand the portfolio of Pure-owned boutique hotels operating under the Hotel PURE brand.
The company initially began growing its operations primarily in the United States. However most recently, major opportunities in Central America began presenting themselves, giving Oriens the ability to retool its business model. Now the company is positioned to acquire, own and operate its own properties – which would be marketed under the new brand with occupancies handled by the re-launched online booking engine system.
Ultimately, Pure intends to become a top-tier hotel brand operator and Internet booking and marketing service provider, qualifying as a preferred supplier to lending institutions. The company also intends to establish an invaluable international footprint with its online booking engine technology and marketing offerings; making that segment of its business a prime acquisition target for major online travel search and booking engine companies. Advancement toward this goal is guided by an executive management team with deep expertise in technology, banking, management, hospitality, branding and marketing, technical development and more. Disclaimer
Pure Hospitality Solutions, Inc. Company Blog
Pure Hospitality Solutions, Inc. News:
PURE Hospitality Solutions Announces NEW Online Hotel Booking Engine; OVEEDIA
PURE Hospitality Solutions Discusses 2015 Initiatives
PURE Announces Retooled Booking Software: 2015 Launch, Slated to Be Industry Regional Leader
Pan Global Corp. (PGLO)
The QualityStocks Daily Newsletter would like to spotlight Pan Global Corp. (PGLO). Today, Pan Global Corp. closed trading at $0.0099, up 22.22%, on 137,175 volume with 9 trades. The stock’s average daily volume over the past 60 days is 86,721, and its 52-week low/high is $0.005/$0.28.
Pan Global Corp. (PGLO) is focused on building the world’s green economy by developing, building, owning, and operating the necessary infrastructure. Current opportunities are currently concentrated on developing projects in India, specifically in the areas of hydro-power generation, solar PV, geo-thermal, sustainable agriculture, and green construction.
The India growth story is frequently compared to China, which has sustained above-average annual growth for three decades, whereas India’s take-off growth began at a later stage. During the last decade, India’s growth has averaged approximately 8% per year. India is poised for high GDP growth that will be sustained for decades to come.
Within the Indian market there are available various government-backed incentives programs, including those which provide direct tariff subsidies as well as market-based tariff support through renewable energy credits. Assessing project viability on a case by case basis, Pan Global seeks to invest in projects both as owner-developers and/or as partners with other developers.
Pan Global’s business strategy is an extension of the company’s commitment to improve human well-being and social equity, while significantly reducing environmental risks and ecological scarcities. By developing a series of highly environmentally sustainable and high ROI projects, Pan Global aims to accelerate business growth. Disclaimer
Pan Global Corp. Company Blog
Pan Global Corp. News:
Pan Global, Corp. Comments on Industry Report That the India Renewable Energy Market Opportunity Is Worth USD $10.5 Billion by 2017
Pan Global, Corp. Shareholder Update: Small-Hydro Plant Connected to Power Grid in Northern India
Pan Global, Corp. Increases Equity Stake in 5.7 MW Small-Hydro Plant in Northern India
Coastal Integrated Services Inc. (COLV)
The QualityStocks Daily Newsletter would like to spotlight Coastal Integrated Services Inc. (COLV). Today, Coastal Integrated Services Inc. closed trading at $0.1718, even with the previous session close, on 25 volume with 1 trade. The stock’s average daily volume over the past 60 days is 53,592, and its 52-week low/high is $0.02/$7.00.
Coastal Integrated Services Inc. (COLV) is targeting the multi-billion dollar disposable beverage sector with the application of the unique technology and innovation developed by its wholly owned subsidiary Simply Lids, Inc. The company's specialty is disposable beverage lids in the food services industry.
Simply Lids' patented technologies provide a safer, more enjoyable drinking experience, without splashing or spills. The company's product designs also enable the added benefit of unique marketing opportunities that have never been realized in this industry sector.
The current standards for beverages are either a flimsy lid that requires the user to tear a pie-shaped mouth hole, or a tiny hole that you have to suck the liquid out like a child’s slippy cup. Frustrating and unsafe. The refreshingly improved design and customization options offered by Simply Lids allows users to enjoy their beverages like there is no lid at all while keeping liquid from splashing out.
The lids are aimed at a $20 billion dollar opportunity in the food services industry where there is astonishing no competition. The use of a new more environmentally friendly plastic with a lower carbon footprint also ensures that Simply Lids / COLV is working towards a more sustainable product for future generations. To date, Simply Lids has won the innovative new product award at the Seattle Coffee Fest Show, received designation as 10 out of 10 by Trend Hunter which indicates placement in the top 20 trends for 2014, and nomination for the prestigious Edison Award. Disclaimer
Coastal Integrated Services Inc. Company Blog
Coastal Integrated Services Inc. News:
Coastal Integrated Services, Inc. (COLV) Announces Engagement of QualityStocks Investor Relations Services
Coastal Nominated for Prestigious Edison Award
Coastal in Top Twenty Trends for 2014
Zenosense, Inc. (ZENO)
The QualityStocks Daily Newsletter would like to spotlight Zenosense, Inc. (ZENO). Today, Zenosense, Inc. closed trading at $0.2475, up 10.00%, on 71,850 volume with 16 trades. The stock’s average daily volume over the past 60 days is 156,270 and its 52-week low/high is $0.15/$1.00.
Zenosense, Inc. (ZENO) is developing and intends to market a novel device to enable hospitals to detect Methicillin-resistant Staphylococcus Aureus (MRSA) bacterial contamination, a major constituent of Hospital Acquired Infections (HAIs). The annual costs of treating hospitalized MRSA patients are estimated to be between $3.2 billion and $4.2 billion in the United States alone. MRSA infected patients are likely to spend three times as long in a hospital stay at three times the cost, and are five times more likely to die than an uninfected patient.
Early detection of MRSA and HAIs in general is vital. Recent studies suggest that implementing prevention practices can lead to up to a 70 percent reduction in certain HAIs with a financial benefit of using these prevention practices estimated to be as high as $25.0 billion to $31.5 billion in medical cost savings in the United States alone (according to a report by the Centers for Disease Control and Prevention, part of the US Department of Health and Human Sciences). Currently, no cost effective early detection device is available.
The Zenosense MRSA detection device is expected to act like a “smoke detector” for MRSA; designed to detect MRSA in the environment or infected patient, even before a patient demonstrates any obvious symptoms, satisfying this huge unmet need.
Zenosense has an agreement with leading European sensor developer Sgenia Group, which is developing such a device exclusively for Zenosense through their subsidiary Zenon Biosystem. The estimated manufacturing cost per device is under $100 USD and possibly as low as $50 USD. The Zenosense device, utilizing established Sgenia programming and patent-pending hardware, utilizes a single sensor to perform an infinite number of scans, creating tens of thousands of "virtual sensors". The low cost and compact design of the Zenosense device, if successfully developed, would make it possible to be worn by individuals, as well as placed in numerous sensitive areas in the healthcare setting.
Zenosense has a streamlined management team experienced in high-level marketing in the medical sector, supported by the outsourced Zenon Biosystem scientific/development team of qualified personnel with extensive knowledge and experience in the development of sensors. Both of these teams will fuse together through a high level advisory board of experienced professionals. A cost-effective Zenosense MRSA detection device, once developed, is expected to be in high demand, driven by patient safety, cost and insurance considerations. Disclaimer
Zenosense, Inc. Company Blog
Zenosense, Inc. News:
Zenosense, Inc. - Hospital Collaboration - 400 Person Lung Cancer Detection Trial
Zenosense, Inc.; Stock Now DTC DWAC/FAST Eligible
Zenosense, Inc. Reports Manufacturing of Pre-Commercial Lung Cancer Detection Device
Nhale, Inc. (NHLE)
The QualityStocks Daily Newsletter would like to spotlight Nhale, Inc. (NHLE). Today, Nhale, Inc. closed trading at $0.1502, up 11.26%, on 69,680 volume with 23 trades. The stock’s average daily volume over the past 60 days is 85,214, and its 52-week low/high is $0.111/$1.33.
Nhale, Inc. (NHLE) develops and sells leading-edge technology in alignment with its mission to become a recognized, premier innovator in cannabis cultivation, dispensaries, testing and scientific products. Nhale explores innovations that will position the company on the front lines of the marijuana revolution.
Nhale is currently aggressively focused on grow operations in states where cannabis is legal, or soon to be legal, such as Oregon, Alaska and Florida. As an increasing number of states move towards legalization for medical or recreational use, growers are positioned to benefit from economies of scale due to escalating demand. Focusing on candidates in the cultivation space, Nhale is poised grow into a successful, sustainable enterprise through product or company acquisition in this explosive space.
Growpod, Nhale’s self-contained grow environment technology, is one of the company’s products and an entry point into the promising cultivation technology space. Growpod uses “controlled environment agriculture” to optimize plant development, plant quality and production efficiency in all climates and seasons.
Nhale believes innovation produces profitability, especially in growth-stage organizations entering emerging industries. This belief guides Nhale’s strong commitment to develop and commercialize cutting-edge consumer-oriented products primed for rapid commercialization. The company has identified strategic industry partnerships to support this growth objective and to secure an increasing footprint in the booming marijuana market. Disclaimer
Nhale, Inc. Company Blog
Nhale, Inc. News:
Nhale Expands Acquisition Effort Toward $10 Billion Medical Marijuana Market
Nhale (NHLE) Receives $10 Million Commitment to Complete Acquisitions
Nhale (NHLE) Forecasts Revenues of More Than $30 Million in 2015 From Deals Under Consideration & Receives $10 Million Commitment to Complete Acquisitions
IFAN Financial, Inc. (IFAN)
The QualityStocks Daily Newsletter would like to spotlight IFAN Financial, Inc. (IFAN). Today, IFAN Financial, Inc. closed trading at $0.685, up 5.38%, on 1,259,222 volume with 433 trades. The stock’s average daily volume over the past 60 days is 538,210, and its 52-week low/high is $0.0114/$0.675.
IFAN Financial, Inc. (IFAN) and its wholly owned subsidiaries, iPIN Technologies and Mobicash America, are engaged in the design, development and distribution of software that enhances and enables mobile payments. The San Diego-based company has a growing portfolio of solutions, including the ability to use a debit card and corresponding PIN number while purchasing online via mobile phone, tablet, or computer and peer-to-peer cash transfers.
Keeping pace with the evolution of the information and communication (ICT) market, iPIN Technologies intends to provide a range of processing services for the industry’s future devices. The company is currently developing a new method of online selling through debit card payments and processing. iPIN technology attaches to any smartphone through the headphone jack and converts the device into a consumer PIN debit, same-as-cash payment solution. Using the iPIN Debit app, transactions are processed through the private and secure iPIN Technologies Network.
Mobicash America is an early-stage technology company that develops mobile payment solutions. The company’s platform product, Quidme, utilizes the text messaging function of a mobile phone, allowing the technology to operate on almost any phone or network, with or without data service. The functionality of the Quidme platform allows users to pay bills, purchase goods and services, and to send money to friends and relatives located locally or internationally via simple text message.
IFAN Financial continues to explore opportunities to expand its product portfolio to meet the growing demands for consumer/merchant convenience, speed and security within the mobile commerce market. Products in development will combine the functionality of social media, e-commerce and banking with the broader conveniences of the mobile environment. Disclaimer
IFAN Financial, Inc. Company Blog
IFAN Financial, Inc. News:
IFAN Financial Announces $1 Million Private Placement
IFAN Financial Reaches Technology Development Milestones, Receives Approval From Apple and Google
IFAN Financial, Inc. (IFAN) CEO Featured in Exclusive QualityStocks Interview
Cleartronic, Inc. (CLRI)
The QualityStocks Daily Newsletter would like to spotlight Cleartronic, Inc. (CLRI). Today, Cleartronic, Inc. closed trading at $0.08, even for the day. The stock’s average daily volume over the past 60 days is 2,118, and its 52-week low/high is $0.04/$0.5499.
Cleartronic, Inc.(CLRI) is a technology holding company that creates and acquires operating subsidiaries to develop, manufacture and sell products, services and integrated systems to government agencies and business enterprises.
VoiceInterop, Inc., a wholly owned subsidiary, is a provider of patented IP communication gateways and communication software. Its gateways are marketed worldwide direct to customers as well as through a network of value added resellers. VoiceInterop has also developed an interoperable communication solution for use by airports. The company markets, installs and supports this interoperability solution directly to airports. International airports currently using the VoiceInterop communication solution include Dulles, Reagan, Omaha, Cincinnati, Green Bay and West Palm Beach.
A recent license agreement provides Cleartronic with the right to market Collabria LLC’s revolutionary ReadyOp™ command, control and communication platform. ReadyOp is a web-based application that integrates multiple databases and a robust communications platform supporting day-to-day activities for planning and managing small- and large-scale events. ReadyOp is designed for fast, efficient access to information and for communication with multiple persons, groups and agencies. ReadyOp is currently being used by numerous federal, state and local government agencies and private enterprises.
Backed by a management team committed to growing its business and finding ways to create value for shareholders, Cleartronic is well-positioned to grow in a broad array of markets. The company has a solid business plan in place that maximizes available resources for accelerated growth and has proven its ability to identify strong business opportunities. Disclaimer
Cleartronic, Inc. Company Blog
Cleartronic, Inc. News:
Cleartronic, Inc. (CLRI) Announces Capitalization Benefit Plan and Expansion of Board of Directors
Cleartronic Announces License Agreement With Collabria LLC
Cleartronic, Inc. (CLRI) Developing 'Capitalization Benefit Plan'
Today's Top 3
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Boreal Water Collection, Inc. (BRWC) to Exhibit at China's Largest Food Show
- Cannabics Pharmaceuticals, Inc. (CNBX) engages with Mountain High Products in Colorado
- Cleartronic, Inc. (CLRI) Announces Capitalization Benefit Plan and Expansion of Board of Directors
- Coastal Integrated Services, Inc. (COLV) Announces Engagement of QualityStocks Investor Relations Services
- Consorteum Holdings, Inc. (CSRH) Signs License Agreement With NYG Holdings
- Dominovas Energy Corp. (DNRG) Key Management Featured in Exclusive QualityStocks Interview
- Falcon Crest Energy (FCEN) Optimistic About Prospecting in Powder River Basin
- IFAN Financial, Inc. (IFAN) Announces $1 Million Private Placement
- MIT Holding, Inc. (MITD) Announces Engagement of QualityStocks Investor Relations Services
- Nhale, Inc. (NHLE) Expands Acquisition Effort Toward $10 Billion Medical Marijuana Market
- One World Holdings, Inc. (OWOO) One World Doll Project Expands Retail Presence in Texas With Fiesta Mart
- Pan Global Corp. (PGLO) Comments on Industry Report That the India Renewable Energy Market Opportunity Is Worth USD $10.5 Billion by 2017
- Puget Technologies, Inc. (PUGE) Moves Company Headquarters to Englewood, CO
- Pure Hospitality Solutions, Inc. (PNOW) PURE Hospitality Solutions Discusses 2015 Initiatives
- Sibling Group Holdings, Inc. (SIBE) Interviewed by TheStockRadio.com
- Start Scientific, Inc. (STSC) Signs Farmout Agreement for Flora Field, Madison County, Mississippi
- Technology Applications International, Inc. (NUUU) Rejuvel Int'l, Inc. Will Have its Products Included in Celebrity Gift Bags at the 15th Annual Latin GRAMMY® Awards Show at the MGM Grand in Las Vegas
- VistaGen Therapeutics, Inc. (VSTA) Signs Letter of Intent With National Institute of Mental Health for NIH-Sponsored Phase 2 Clinical Study of AV-101 in Major Depressive Disorder
- Well Power Inc. (WPWR) to host second webinar on proprietory micro-refinery technology
- WordLogic Corp. (WLGC) Inks Deal to Monetize Intellectual Property for General Electric (GE)
- WRIT Media Group, Inc. (WRIT) Announces Product Updates and NASCAR Event Recap
- Zenosense, Inc. (ZENO) Hospital Collaboration - 400 Person Lung Cancer Detection Trial